D. Porte

Relationship of islet function to insulin action in human obesity.

J. Halter, D. Porte, W. Ward, 1987, The Journal of clinical endocrinology and metabolism.

Aldose reductase inhibition improves nerve conduction velocity in diabetic patients.

J. Halter, K. Polonsky, M. Pfeifer, 1983, The New England journal of medicine.

Mechanisms of impaired acute insulin release in adult onset diabetes: studies with isoproterenol and secretin.

J. Halter, D. Porte, Jeffrey B. Halter, 1978, The Journal of clinical endocrinology and metabolism.

A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus.

J. Halter, D. Porte, R. Robertson, 1976, The Journal of clinical investigation.

Nerve conduction abnormalities in untreated maturity-onset diabetes: relation to levels of fasting plasma glucose and glycosylated hemoglobin.

J. Halter, D. Porte, E. Halar, 1979, Annals of internal medicine.

Glycemic control and nerve conduction abnormalities in non-insulin-dependent diabetic subjects.

J. Halter, M. Pfeifer, D. Porte, 1981, Annals of internal medicine.

The relation between postheparin lipolytic activity and plasma triglyceride in myxedema.

D. Porte, R. H. Williams, D. O'Hara, 1966, Metabolism: clinical and experimental.

Inhibition of in vivo insulin secretion by prostaglandin E1.

D. Porte, R. Robertson, E. Bierman, 1974, The Journal of clinical investigation.

Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.

J. Halter, M. Pfeifer, L. Harker, 1984, The Journal of clinical investigation.